4.5 Article

SARS-CoV-2 Effects on Psychophysical Olfactory Scores: Prospective Study With Evaluation Before and 60-Days After Infection

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination

Luigi A. Vaira et al.

Summary: This study investigated the clinical profile of patients who developed COVID-19 after full vaccination. Chemosensory dysfunction, particularly olfactory and gustatory dysfunction, was found to be common symptoms, suggesting that sudden loss of smell and taste could continue to be a useful and specific diagnostic marker even in vaccinated subjects.

LARYNGOSCOPE (2022)

Article Otorhinolaryngology

Prevalence of Persistent Olfactory Disorders in Patients With COVID-19: A Psychophysical Case-Control Study With 1-Year Follow-up

Luigi Angelo Vaira et al.

Summary: This study evaluated olfactory dysfunction in patients after COVID-19 and found that the prevalence of OD was significantly higher in the COVID-19 group compared to the control group, indicating that this result was not affected by the baseline prevalence of OD in the general population.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2022)

Review Otorhinolaryngology

Self-reported olfactory and gustatory dysfunction and psychophysical testing in screening for COVID-19: A systematic review and meta-analysis

Minh P. Hoang et al.

Summary: Self-reported olfactory and gustatory dysfunction, as well as unvalidated and limited psychophysical tests, although showing high specificity and DOR values, were not sensitive enough in screening for COVID-19 and were not suitable adjuncts in ruling out the disease.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)

Article Biology

The Effects of Persistent Olfactory and Gustatory Dysfunctions on Quality of Life in Long-COVID-19 Patients

Luigi Angelo Vaira et al.

Summary: Persistent olfactory and gustatory dysfunctions are common symptoms of long-COVID-19 syndrome and significantly impact the mental health component of patients' quality of life.

LIFE-BASEL (2022)

Editorial Material Immunology

Why Does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in Coronavirus Disease 2019

Rafal Butowt et al.

Summary: The omicron variant of SARS-CoV-2 causes lower prevalence of anosmia compared to previous variants, possibly due to changes in tissue infection mechanisms. The new mutations make omicron less capable of infecting olfactory cells, thereby sparing olfactory function.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Medicine, Research & Experimental

Modified Olfactory Training Is an Effective Treatment Method for COVID-19 Induced Parosmia

Aytug Aldundag et al.

Summary: This study retrospectively investigated the effectiveness of modified olfactory training in treating parosmia induced by COVID-19 infection. The results showed that olfactory training was effective in improving parosmia symptoms and increasing discrimination abilities in patients.

LARYNGOSCOPE (2022)

Article Otorhinolaryngology

Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant

Paolo Boscolo-Rizzo et al.

Summary: The prevalence and severity of COVID-19-associated smell and taste dysfunction has significantly decreased with the advent of the Omicron variant but it still remains above 30%.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)

Letter Medicine, General & Internal

Olfactory Dysfunction in Patients With Mild COVID-19 During Gamma, Delta, and Omicron Waves in Rio de Janeiro, Brazil

Cynthia Chester Cardoso et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Editorial Material Medicine, General & Internal

Smell and taste dysfunction after covid-19 Health systems are unprepared for the scale of the challenge

Paolo Boscolo-Rizzo et al.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Review Otorhinolaryngology

Olfactory Training for Postviral Olfactory Dysfunction: Systematic Review and Meta-analysis

Nrusheel Kattar et al.

Summary: Meta-analysis of existing data confirms clinically significant improvements in PVOD associated with OT. There is variability among OT protocols that may benefit from further optimization. Existing data supports the use of OT for the treatment of existing and newly emerging cases of PVOD.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2021)

Article Otorhinolaryngology

Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell

Luca D'Ascanio et al.

Summary: This study found that olfactory dysfunction is more common in COVID-19 patients compared to healthy controls, with outpatients paradoxically reporting loss of smell more commonly than inpatients. Most patients with olfactory dysfunction recovered within 30 days, indicating a favorable prognosis.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2021)

Article Medicine, Research & Experimental

Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients

Jeyasakthy Saniasiaya et al.

Summary: A systematic review and meta-analysis found that the overall prevalence of olfactory dysfunction in COVID-19 patients is 47.85%, with European patients having the highest prevalence and Asian patients the lowest. Discrepancies between objective and subjective evaluations suggest further studies are needed.

LARYNGOSCOPE (2021)

Article Microbiology

Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients

Luigi Angelo Vaira et al.

Summary: Objective evaluation of olfactory function in COVID-19 patients is challenging due to logistical and safety issues. Psychophysical tests provide more accurate results than patient self-reports. Olfactory disturbances appear to be largely independent of epidemiological and clinical characteristics.

PATHOGENS (2021)

Article Otorhinolaryngology

Validity and reliability of the COVID-19 symptom index, an instrument evaluating severity of general and otolaryngological symptoms

Jerome R. Lechien et al.

Summary: A clinical instrument, the CSI, was developed to evaluate symptoms of COVID-19 patients, showing high internal consistency, validity, and responsiveness to change.

ACTA OTO-LARYNGOLOGICA (2021)

Article Clinical Neurology

Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction

Sven Saussez et al.

Summary: No clinical markers were found to predict the evolution of olfactory dysfunction (OD) at 60 days. Patients with poor olfactory outcome at 60 days had lower levels of salivary and nasal antibodies, suggesting a role for local immune responses in the persistence of COVID-19 related OD.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Microbiology

Objective Olfactory Findings in Hospitalized Severe COVID-19 Patients

Jerome R. Lechien et al.

PATHOGENS (2020)

Article Otorhinolaryngology

Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study

L. A. Vaira et al.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2020)

Article Medicine, Research & Experimental

Patterns of Olfactory Impairment Reflect Underlying Disease Etiology

Katherine L. Whitcroft et al.

LARYNGOSCOPE (2017)

Article Psychology, Clinical

Cognitive factors in odor detection, odor discrimination, and odor identification tasks

Margareta Hedner et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2010)